Glass Jacobson Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Glass Jacobson Investment Advisors's PFE Position: Q2 2026 in Review
Glass Jacobson Investment Advisors increased its Pfizer (PFE) stake by 7.1% in Q2 2026, buying an estimated $3.4K and bringing the position to 1,957 shares worth $47.1K. The position accounts for 0.01% of the portfolio, ranked #337.
Glass Jacobson Investment Advisors first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.23M in Q4 2022. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Glass Jacobson Investment Advisors held 1,957 shares of Pfizer worth $47.1K as of Q2 2026.
- Glass Jacobson Investment Advisors bought 130 Pfizer shares in Q2 2026, an estimated $3.4K.
- Pfizer made up 0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #337 holding.
- Glass Jacobson Investment Advisors first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
- Glass Jacobson Investment Advisors's Pfizer position peaked at $1.23M in Q4 2022.
- 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.